J. Fukushima

发表

Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1.

W. Koff, T. Yasuda, N. Ishii, 1997, AIDS research and human retroviruses.

Induction of HIV‐1 Nef‐specific cytotoxic T lymphocytes by Nef‐expressing DNA vaccine

H. Mohri, J. Fukushima, K. Hamajima, 1996, American journal of hematology.

HIV‐1‐specific cell‐mediated immunity is enhanced by co‐inoculation of TCA3 expression plasmid with DNA vaccine

M. Dorf, H. Bukawa, N. Ishii, 1997, Immunology.

Antibody Responses Raised against a Conformational V3 Loop Peptide of HIV‐1

H. Bukawa, J. Fukushima, K. Hamajima, 1995, Microbiology and immunology.

Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.

J. Miyazaki, K. Okuda, T. Yasuda, 1997, Journal of immunology.

Activation of HIV‐1‐specific immune responses to an HIV‐1 vaccine constructed from a replication‐defective adenovirus vector using various combinations of immunization protocols

J. Fukushima, K. Hamajima, K. Xin, 2001, Clinical and experimental immunology.

Th1‐biased immune responses induced by DNA‐based immunizations are mediated via action on professional antigen‐presenting cells to up‐regulate IL‐12 production

K. Okuda, B. Wahrén, J. Fukushima, 2000, Clinical and experimental immunology.

Induction of HIV‐1 Specific Mucosal Immune Responses by DNA Vaccination

B. Wahrén, J. Fukushima, K. Okuda, 1997, Scandinavian journal of immunology.

Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1

H. Mohri, N. Ishii, J. Fukushima, 1997, Infection and immunity.

DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity.

W. Koff, H. Bukawa, J. Fukushima, 1997, Vaccine.

Differential Gene Expression of TGF‐β Isoforms and TGF‐β Receptors During the First Trimester of Pregnancy at the Human Maternal‐Fetal Interface

F. Hirahara, J. Fukushima, S. Kawamoto, 1998 .

Hyperoxia exaggerates bacterial dissemination and lethality in Pseudomonas aeruginosa pneumonia.

T. Standiford, Tetsuya Matsumoto, K. Tateda, 2009, Pulmonary pharmacology & therapeutics.

Induction of Systemic and Mucosal Immune Responses to Human Immunodeficiency Virus Type 1 by a DNA Vaccine Formulated with QS-21 Saponin Adjuvant via Intramuscular and Intranasal Routes

H. Mohri, N. Ishii, J. Fukushima, 1998, Journal of Virology.

Immunomodulatory effects of a plasmid expressing B7‐2 on human immunodeficiency virus‐1‐specific cell‐mediated immunity induced by a plasmid encoding the viral antigen

N. Ishii, J. Fukushima, K. Tani, 1997, European journal of immunology.

The search for a potent DNA vaccine against AIDS: the enhancement of immunogenicity by chemical and genetic adjuvants.

K. Okuda, J. Fukushima, S. Sasaki, 1998, Anticancer research.

Activation of I-A Gene Products by Aß Gene Transfection Using Bovine Papilloma Virus — Vector Systems

I. Aoki, J. Fukushima, S. Kawamoto, 1987 .

HIV-DNA vaccination following transfer of a large number of activated T cells enhances immunoresponses against HIV-1.

J. Fukushima, K. Hamajima, K. Xin, 2000, Viral immunology.

Strong augment effect of IL-12 expression plasmid on the induction of HIV-specific cytotoxic T lymphocyte activity by a peptide vaccine candidate.

H. Bukawa, J. Fukushima, T. Kaneko, 1997, Clinical immunology and immunopathology.

Macrophage inflammatory protein‐1α (MIP‐1α) expression plasmid enhances DNA vaccine‐induced immune response against HIV‐1

J. Fukushima, E. Okada, K. Hamajima, 1999 .

Activation of alveolar macrophages in acid-injured lung in rats: Different effects of pentoxifylline on tumor necrosis factor-&agr; and nitric oxide production

I. Kudoh, J. Fukushima, H. Miyazaki, 2001, Critical care medicine.

Enhancement of cell-mediated immunity against HIV-1 induced by coinnoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12.

J. Miyazaki, W. Koff, N. Ishii, 1997, Journal of immunology.

DNA-Plasmids of HIV-1 Induce Systemic and Mucosal Immune Responses

K. Okuda, B. Wahrén, J. Fukushima, 1999, Biological chemistry.

Prophylactic and therapeutic vaccine against Pseudomonas aeruginosa keratitis using bacterial membrane vesicles.

N. Mizuki, J. Fukushima, K. Okuda, 2021, Vaccine.

Cytokine and costimulatory factor-encoding plasmids as adjuvants for DNA vaccination.

J. Fukushima, S. Kawamoto, K. Okuda, 2000, Methods in molecular medicine.

Intranasal administration of HIV-DNA vaccine formulated with a polymer, carboxymethylcellulose, augments mucosal antibody production and cell-mediated immune response.

J. Fukushima, T. Kaneko, K. Hamajima, 1998, Clinical immunology and immunopathology.

Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity.

J. Fukushima, K. Hamajima, K. Xin, 1999, Clinical immunology.

Immunomodulatory effect of a plasmid expressing CD40 ligand on DNA vaccination against human immunodeficiency virus type‐1

J. Inoue, J. Fukushima, K. Hamajima, 1999, Immunology.

Comparison of Intranasal and Intramuscular Immunization against Human Immunodeficiency Virus Type 1 with a DNA-Monophosphoryl Lipid A Adjuvant Vaccine

F. Hirahara, H. Mohri, N. Ishii, 1998, Infection and Immunity.

Intranasal administration of human immunodeficiency virus type‐1 (HIV‐1) DNA vaccine with interleukin‐2 expression plasmid enhances cell‐mediated immunity against HIV‐1

P. Shapshak, N. Ishii, J. Fukushima, 1998, Immunology.

Human immunodeficiency virus type‐1‐specific immune responses induced by DNA vaccination are greatly enhanced by mannan‐coated diC14‐amidine

K. Okuda, J. Ruysschaert, F. Hirahara, 1997, European journal of immunology.

Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate

H. Kiyono, H. Bukawa, J. Fukushima, 1995, Nature Medicine.

Long-Range Effect of Mutation of Calcium Binding Asparates on the Catalytic Activity of Alkaline Protease from Pseudomonas aeruginosa

Y. Hata, Y. Shibano, J. Fukushima, 1998 .

Site-Directed Mutagenesis of His-176 and Glu-177 in Pseudomonas aeruginosa Alkaline Protease : Effect on Catalytic Activity

Y. Hata, Y. Shibano, J. Fukushima, 1997 .

Complete nucleotide sequence of the structural gene for alkaline proteinase from Pseudomonas aeruginosa IFO 3455

H. Kawasaki, K. Suzuki, J. Fukushima, 1990, Infection and immunity.

Structural gene and complete amino acid sequence of Pseudomonas aeruginosa IFO 3455 elastase

J. Fukushima, S. Kawamoto, K. Okuda, 1989, Journal of bacteriology.

Cloning and characterization of elastase structural gene from Pseudomonas aeruginosa IFO 3455.

S. Yamamoto, J. Fukushima, S. Kawamoto, 1988, Biochemical and biophysical research communications.

Induction of entry into the stationary growth phase in Pseudomonas aeruginosa by N-acylhomoserine lactone.

K. Tanaka, J. Fukushima, S. Kawamoto, 1998, FEMS microbiology letters.

The pituitary-specific regulatory gene GHF1 contains a minimal cell type-specific promoter centered around its TATA box.

M. Karin, J. Fukushima, A. McCormick, 1991, Genes & development.

NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene.

S. Ohno, J. Fukushima, S. Kawamoto, 1994, Journal of immunology.

Synthetic Peptide From the V3 Loop Consensus Motif With A Potent Anti-HIV Activity Inhibits Ristocetin-Mediated vWF-GPIb Interaction

H. Mohri, J. Fukushima, S. Kawamoto, 1997, Peptides.

Reliable Enzyme‐Linked Immunosorbent Assay Systems for Pathogenic Factors of Pseudomonas aeruginosa Alkaline Proteinase, Elastase, and Exotoxin A: A Comparison of Methods for Labeling Detection Antibodies with Horseradish Peroxidase

J. Fukushima, K. Okuda, T. Shigematsu, 2007, Microbiology and immunology.

Cloning and expression of the alkaline proteinase gene from Pseudomonas aeruginosa IFO 3455

J. Fukushima, S. Kawamoto, K. Okuda, 1989, Journal of bacteriology.

Y Pseudomonas aeruginosa . several non-elastase-producing strains of coli with the elastase structural gene from Detection of elastase production in Escherichia

Hamajima, J. Fukushima, S. Kawamoto, 2022 .

Detection of elastase production in Escherichia coli with the elastase structural gene from several non-elastase-producing strains of Pseudomonas aeruginosa

Y. Miyagi, J. Fukushima, K. Hamajima, 1991, Journal of bacteriology.

The human foamy virus Bel-1 transcription factor is a sequence-specific DNA binding protein

B. Cullen, J. Fukushima, W. Blair, 1996, Journal of virology.

Site-directed mutagenesis of Glu-141 and His-223 in Pseudomonas aeruginosa elastase: catalytic activity, processing, and protective activity of the elastase against Pseudomonas infection

Y. Shibano, N. Ishii, J. Fukushima, 1993, Infection and immunity.

Genetic control of in vivo tumor necrosis factor production in mice.

H. Sekihara, T. Yamakawa, Y. Yamakawa, 1996, Clinical immunology and immunopathology.

Molecular cloning and nucleotide sequence of rat brain argininosuccinate lyase cDNA with an extremely long 5'-untranslated sequence: evidence for the identity of the brain and liver enzymes.

J. Fukushima, T. Kaneko, S. Kawamoto, 1989, Brain research. Molecular brain research.

Structural gene and complete amino acid sequence of Vibrio alginolyticus collagenase.

B. Keil, A. Gilles, Y. Shibano, 1992, The Biochemical journal.

Gene expression of tumour necrosis factor-α (TNF-α) and heat-shock protein (HSP) 70 in patients with BehÇet's disease

S. Ohno, T. Yamakawa, Y. Yamakawa, 2004, Archives of Dermatological Research.

Intracellular receptor-type transcription factor, LasR, contains a highly conserved amphipathic region which precedes the putative helix-turn-helix DNA binding motif.

J. Fukushima, K. Okuda, Z. You, 1994, Nucleic acids research.

Arginine-481 mutation abolishes ligand-binding of the AMPA-selective glutamate receptor channel alpha1-subunit.

M. Mishina, J. Fukushima, K. Hamajima, 1997, Brain research. Molecular brain research.

Differential gene expression of TGF-beta isoforms and TGF-beta receptors during the first trimester of pregnancy at the human maternal-fetal interface.

F. Hirahara, J. Fukushima, S. Kawamoto, 1998, American journal of reproductive immunology.

Differential Gene Expression of TGF-P Isoforms

F. Hirahara, J. Fukushima, S. Kawamoto, 2011 .

Iron‐Mediated Regulation of Alkaline Proteinase Production in Pseudomonas aeruginosa

J. Fukushima, S. Kawamoto, K. Okuda, 2001, Microbiology and immunology.

[Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection].

K. Okuda, J. Fukushima, K. Shindo, 1997, Arerugi = [Allergy].

Expression of the α1 and α2 Subunits of the AMPA‐Selective Glutamate Receptor Channel in Insect Cells using a Baculovirus Vector

K. Sakimura, M. Mishina, J. Fukushima, 1993 .

Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1.

J. Fukushima, E. Okada, K. Hamajima, 1999, Clinical and experimental immunology.

Purification and characterization of LasR as a DNA-binding protein.

J. Fukushima, S. Kawamoto, K. Okuda, 1996, FEMS microbiology letters.

Dissection of the promoter/operator region and evaluation of N-acylhomoserine lactone mediated transcriptional regulation of elastase expression in Pseudomonas aeruginosa.

J. Fukushima, S. Kawamoto, K. Okuda, 1997, FEMS microbiology letters.

Hyperoxia exaggerates bacterial dissemination and lethality in Pseudomonas aeruginosa pneumonia.

T. Standiford, Tetsuya Matsumoto, K. Tateda, 2009, Pulmonary pharmacology & therapeutics.